Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

MacroGenics studies MGD-014 in patients with HIV infection on suppressive ART

Oct. 22, 2018

Aelix and Gilead collaborate to study HTI T-cell vaccine with vesatolimod in HIV

Oct. 19, 2018

ST Pharm discovers new HIV integrase inhibitors

Oct. 19, 2018

GS-6207 shows long-acting nonclinical pharmacokinetic profile

Oct. 11, 2018

Vedolizumab may help eliminate HIV infection by attenuating lymphoid aggregates

Oct. 9, 2018

Two-fisted punch prevents HIV rebound

Oct. 8, 2018

NK problems facilitate bnAbs in HIV

Oct. 2, 2018

BIT225-009 phase II study demonstrates significant immunological benefits in HIV-infected patients

Oct. 1, 2018

Combination antibodies suppress HIV and resistance

Oct. 1, 2018

First patient enrolled in phase IIa HIV study of GnRH agonist ISR-048

Sep. 21, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...